Our study of tousled-like kinase 2 highlighted in CDMRP 2019 annual report
September 30, 2019/
Our signature study of Tousled-Like Kinase 2 was highlighted in 2019 annual report of the Congressionally Directed Medical Research Programs of the Department of Defense. Read more..